Saturday’s Daily Piece: Expanded Age Indication for Toujeo

Insulin glargine (Toujeo) is now FDA approved for children ages 6 and older with type 1 and 2 diabetes. Previously, Toujeo was indicated for people ages 18 and older with type 1 and 2 diabetes. To learn more about the results EDITION JUNIOR trial, please click below.

https://www.biospace.com/article/fda-approves-sanofi-s-toujeo-for-pediatric-diabetes/

Image result for toujeo in pediatric
This image has an empty alt attribute; its file name is image-6.jpeg

Please share your thoughts and subscribe to receive my blogs.

#pediatrics #diabetes #Toujeo

Follow me on Twitter and Facebook @ReecesPiecesDi and Instagram.

Leave a Reply

Your email address will not be published. Required fields are marked *